Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
LEGN
LEGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LEGN News
Legend Biotech Named One of the Best Revenue Growth Stocks
Feb 07 2026
Yahoo Finance
Deutsche Bank Downgrades Qiagen to Hold, Raises Price Target to $54
Jan 22 2026
Benzinga
Johnson & Johnson Exceeds Earnings Expectations and Raises Forecast Despite Share Decline
Jan 20 2026
Barron's
FDA Draft Guidance Boosts Arcellx (ACLX) and Legend Biotech (LEGN) Stock Prices
Jan 20 2026
seekingalpha
Healthcare Sector Outperforms S&P 500 with 12.52% Gain and 3.20 Health Score
Jan 14 2026
seekingalpha
Initial Week of LEGN Options Trading for August 2026
Dec 19 2025
NASDAQ.COM
Legend Biotech CEO to Present Latest Updates at J.P. Morgan Conference
Dec 17 2025
Globenewswire
Eight Stock Selections to Capitalize on a Robust Sector of the Market
Dec 11 2025
MarketWatch
Cancer Research Boosts Confidence in These Small Biotech Companies
Dec 09 2025
Barron's
Legend Biotech Reports 50.4 Months Median PFS for CARVYKTI® in Triple-Class Exposed Patients
Dec 06 2025
Globenewswire
Legend Biotech Awarded 2025 Foreign Investor of the Year, Investing €165 Million to Expand Cell Therapy Operations
Nov 27 2025
Newsfilter
Legend Biotech Awarded 2025 Foreign Investor of the Year, Investing €165 Million in Cell Therapy Expansion
Nov 27 2025
Globenewswire
Noteworthy LEGN Put and Call Options Set for January 2026
Nov 24 2025
NASDAQ.COM
Barclays Keeps Overweight Rating on Legend Biotech, Reduces Price Target to $90
Nov 13 2025
Benzinga
RBC Capital Keeps Outperform Rating for Legend Biotech, Reduces Price Target to $74
Nov 13 2025
Benzinga
Legend Biotech Corporation Reports Reduced Losses in Q3
Nov 12 2025
NASDAQ.COM
Show More News
